can't afford not to have it is my response IMHO
Post# of 30028
Posted On: 09/25/2014 8:30:00 AM
can't afford not to have it is my response
IMHO it wouldn't take a huge amount of money to begin to line themselves up with a strategic IR / marketing firm - especially in light of all the near term catalysts and key milestones that are expected to put them on the road map of successful Biotech start-ups. But I assure you, the complaints about this poor coverage are there.
I get it as well. But at some point, you have to leave the start-up craddle and step out into the real world. IMHO, now is as good a time as any to start lining up these types of initiatives - not after they happen.
Hopefully, they're planning this strategy to concur simultaneously with a NAS uplisting. I'd like to think so....
All the best, JP
IMHO it wouldn't take a huge amount of money to begin to line themselves up with a strategic IR / marketing firm - especially in light of all the near term catalysts and key milestones that are expected to put them on the road map of successful Biotech start-ups. But I assure you, the complaints about this poor coverage are there.
I get it as well. But at some point, you have to leave the start-up craddle and step out into the real world. IMHO, now is as good a time as any to start lining up these types of initiatives - not after they happen.
Hopefully, they're planning this strategy to concur simultaneously with a NAS uplisting. I'd like to think so....
All the best, JP
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼